Passions

Skiing

Fly-fishing

Staying active

Family

Experience

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

August 6, 2025

Cooley advised MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, on an up to $500 million strategic financing agreement with funds managed by Blackstone.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Adam J. Longenbach
Partner, New York
Asa Henin
Partner, San Diego
Matthew S. Scarano
Associate, San Diego
Margaret Barreto
Associate, San Francisco
Charles A. Watkins II
Associate, Santa Monica
Kavi Huded
Associate, New York
Jeffrey J. Tolin
Partner, New York
David Dalton
Associate, Santa Monica
Natasha Leskovsek
Of Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
Charity Williams
Partner, San Diego
Karen Tsai
Special Counsel, Washington, DC
Dr. Jon Cousin
Partner, Washington, DC
Dr. Jason Valentine
Associate, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Allison Kutner
Associate, New York
Phil Mitchell
Partner, New York
Wyatt Kernell
Associate, Colorado
Kimberly Nguyen
Special Counsel, Reston
Peter Crain
Special Counsel, Reston
Kristine Forderer
Partner, San Francisco

Related Practices & Industries

Blue Owl Capital Extends up to $500 Million in Senior Secured Credit to Madrigal Pharmaceuticals

July 21, 2025

Cooley advised Blue Owl (NYSE: OWL), a leading asset manager redefining alternatives, on an up to $500 million term loan facility for Madrigal Pharmaceuticals (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis.

Read more

Related contacts

Michael Tollini
Partner, Washington, DC
Addison Pierce
Partner, Chicago
Dr. Jon Cousin
Partner, Washington, DC
Geoffrey Spolyar
Partner, Boston
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Steve Flores
Partner, Chicago
Michael Neumeister
Partner, Los Angeles
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Wyatt Kernell
Associate, Colorado
Dr. Asako Kubota
Associate, Washington, DC
Allison Kutner
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Charles A. Watkins II
Associate, Santa Monica
Jeffery Wyzykowski
Patent Agent, Washington, DC
Margie Murphy
Paralegal Specialist, New York

Related Practices & Industries

Philochem AG Announces up to $1.35 Billion License Agreement With RayzeBio

June 10, 2025

Cooley advised Philochem AG, a wholly owned subsidiary of the Philogen Group (Milan Stock Exchange: PHIL), on its definitive license agreement with RayzeBio, a wholly owned subsidiary of Bristol Myers Squibb (NYSE: BMY), granting RayzeBio exclusive worldwide rights to develop, manufacture and commercialize OncoACP3, a clinical-stage therapeutic and diagnostic agent targeting prostate cancer.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Joe Sandys
Special Counsel, London
Alexandra Paterson
Associate, London
Joseph Perry
Associate, Reston
J. Brian Stalter
Special Counsel, New York
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
David Burns
Special Counsel, Washington, DC
Megan Browdie
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Ann Bevitt
Partner, London
Rachel Thorn
Of counsel, New York
Dr. Jon Cousin
Partner, Washington, DC

Related Practices & Industries

Blue Owl Capital Invests up to $262.5 Million in ITM Isotope Technologies Munich SE

May 27, 2025

Cooley advised Blue Owl Capital (NYSE: OWL), an asset manager redefining alternatives, on an up to $262.5 million term loan facility for ITM Isotope Technologies Munich SE, a radiopharmaceutical biotech company dedicated to providing a new generation of radiopharmaceutical therapeutics and diagnostics for hard-to-treat tumors.

Read more

Related contacts

Michael Tollini
Partner, Washington, DC
Addison Pierce
Partner, Chicago
Dr. Jon Cousin
Partner, Washington, DC
Geoffrey Spolyar
Partner, Boston
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Steve Flores
Partner, Chicago
Susan Piascik Christoff
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Wyatt Kernell
Associate, Colorado
Matt Kong
Associate, San Francisco
Dr. Asako Kubota
Associate, Washington, DC
Allison Kutner
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Charles A. Watkins II
Associate, Santa Monica
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC
Margie Murphy
Paralegal Specialist, New York
Larry Teague
Patent Agent, Seattle

Related Practices & Industries

Oberland Capital Invests up to $600 Million in Biohaven

April 28, 2025

Cooley advised Oberland Capital, a private investment firm committed to funding innovation across the global healthcare industry, on its agreement to invest up to $600 million in Biohaven (NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Alexis Finkelberg Bortniker
Partner, San Diego
Dr. Jon Cousin
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Geoffrey Spolyar
Partner, Boston
Stacey A. Bradford
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Margaret Barreto
Associate, San Francisco
Wyatt Kernell
Associate, Colorado
Megan Mojabi (Flynn)
Associate, London
Matthew S. Scarano
Associate, San Diego
Stacy Colter
Senior Paralegal, New York

Related Practices & Industries

View more

Admissions and credentials

Montana

District of Columbia

Registered to practice before the United States Patent and Trademark Office (USPTO)

Rankings and accolades

The Legal 500 US: Patents: Prosecution (Including Re-Examination and Post-Grant Proceedings) (2021, 2025)

Best Lawyers: Ones to Watch – Patent and IP, 2024

Concurrences: Readers’ Choice Antitrust Writing Award for Intellectual Property, 2024

Memberships and affiliations

American Intellectual Property Law Association